# A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients

> **NCT04255602** · PHASE4 · UNKNOWN · sponsor: **Shanghai Tong Ren Hospital** · enrollment: 2120 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Coronary Stent Implantation

## Interventions

- **DRUG:** Ticagrelor 60mg
- **DRUG:** Ticagrelor 90mg

## Key facts

- **NCT ID:** NCT04255602
- **Lead sponsor:** Shanghai Tong Ren Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-19
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 2120 (ESTIMATED)
- **Last updated:** 2023-12-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04255602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04255602, "A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04255602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*